Amr A. Arafat

Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective

Background/Objectives: Obesity is a chronic, multifactorial condition driven by complex neuroendocrine and metabolic pathways that limit the long-term success of lifestyle interventions. Pharmacotherapy has advanced from early monoaminergic agents to incretin-based and multi-rece...